Advertisement

Antiviral Agents

  • David Edwards
Chapter

Abstract

Viruses are the simplest entities able to reproduce and the fact that they are able to maintain and replicate, thus conserving their genetic continuity, is the only link they have with organisms known to be ‘alive’. Because they require a living cell in which to replicate their reproductive cycle is unique amongst living organisms.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

12.4 References and Further Reading

  1. Bauer, D. J. (1972). Thiosemicarbazones. In Chemotherapy of Viral Diseases, Vol. 1 (D. J. Bauer, ed.). Pergamon Press, OxfordGoogle Scholar
  2. Blalock, J. E. and Baron, S. (1977). Interferon-induced transfer of viral resistance between animal cells. Nature, Lond., 269, 422–5CrossRefGoogle Scholar
  3. Burke, D. C. (1977). The status of interferon. Scient. Am., 236, 42–62CrossRefGoogle Scholar
  4. Carrasco, L. (1978). Membrane leakiness after viral infection and a new approach to the development of antiviral agents. Nature, Lond., 272, 694–9CrossRefGoogle Scholar
  5. Cooper, P. D., Steiner-Pryor, A. and Wright, P. J. (1973). A proposed regulator for poliovirus: the equestron. Intervirology, 1, 1–10CrossRefGoogle Scholar
  6. Cossarelli, N. R. (1977). The mechanism of action of inhibitors of DNA synthesis. A. Rev. Biochem., 46, 641–8CrossRefGoogle Scholar
  7. DiMayorca, G. A., Eddy, B. E., Stewart, S. E., Hunter, W. S., Friend, C. and Bendick, A. (1959). Isolation of infective deoxyribonucleic acid from SE polyoma-infected tissue cultures. Proc. nat. Acad. Sci. U.S.A., 45, 1805–8CrossRefGoogle Scholar
  8. Elion, G., Furman, P. A., Fyfe, J. A., Miranda, P. D., Beauchamp, L. A. and Schaeffer, H. J. (1977). Selective action of an antiherpetic agent 9-(2-hydroxyethoxymethyl)guanine. Proc. Natn. Acad. Sci. U.S.A., 74, 5716–20CrossRefGoogle Scholar
  9. Galbraith, A. W. (1976). An appraisal of amantadine in A2 influenza. In Symmetrel in Virology (C. A. S. Wink, ed.). Geigy PharmaceuticalGoogle Scholar
  10. Galbraith, A. W., Oxford, J. S., Schild, G. C. and Watson, G. I. (1970. Protective effect of amino-adamantane on influenza A2 infections in the family environment. Ann. N.Y. Acad. Sci., 173, 29–43CrossRefGoogle Scholar
  11. Galbraith, A. W., Schild, G. C., Potter, C. W. and Watson, G. I. (1973). The therapeutic effect of amantadine in influenza occurring during the winter of 1971–2 assessed by double-blind study. J. R. Coll. gen. Practit., 23, 34–37Google Scholar
  12. Galbraith, A. W., Oxford, J. S., Schild, G. C., Potter, C. W. and Watson, G. I. (1971). Therapeutic effect of 1-adamantanamine hydrochloride is naturally occurring influenza A/HongKong infection. Lancet, ii, 113–5CrossRefGoogle Scholar
  13. Gerber, P. (1962). An infectious deoxyribonucleic acid derived from vacuolating virus SV40. Virology, 16, 96–8CrossRefGoogle Scholar
  14. Grunert, R. R., McGahen, J. W. and Davies, W. L. (1965). The in vivo antiviral activity of 1-adamantanamine (amantadine). 1. Prophylactic and therapeutic activity against influenza virus. Virology, 26, 262–9CrossRefGoogle Scholar
  15. Hermans, I. E. (1977). Antiviral agents. Mayo Clin. Proc., 52, 683–6Google Scholar
  16. Hiss, E. A. and Preston, R. J. (1977). The effect of cytosine arabinoside on the frequency of single strand breaks in DNA of mammalian cells following irradiation or chemical treatment. Biochim. biophys. Acta, 478, 1–8CrossRefGoogle Scholar
  17. Hunt, T. (1978). Interferon, dsRNA and the pleiotypic effector. Nature, Lond., 273, 97–8CrossRefGoogle Scholar
  18. Joklick, W. K. (1964). The intracellular uncoating of poxvirus DNA. I. The fate of radioactively labelled rabbit pox virus. J. mol. Biol., 8, 263–76CrossRefGoogle Scholar
  19. Joklik, W. K. (1968). Studies on the mode of action of two antiviral agents: isatin-β-thiosemicarbazone and interferon. In Medical and Applied Virology (M. Sanders, and E. H. Lennette, eds). Green, St Louis, pp. 299–326Google Scholar
  20. Kates, J. R. and McAuslan, B. R. (1967). Messenger RNA synthesis by a ‘coated’ viral genome. Proc. natn. Acad. Sci. U.S.A., 57, 314–20CrossRefGoogle Scholar
  21. Katz, E. Margolith, E. Felix, H. and Winer, B. (1978). Synthesis of vaccinia viral RNA and proteins in the presence of isatin-β-thiosemicarbazone. Curr. Chemother., 1, 330–2Google Scholar
  22. Kaufman, H. E. and Abel, R. (1974). Abstract No. 40, 14th Interscience Conference on Antimicrobial Agents and ChemotherapyGoogle Scholar
  23. Kerr, I. M. and Brown, R. E. (1978). pppA2’pJ’A2’pJ’A: an inhibitor of protein synthesis synthesized with an enzyme fraction from interferon-treated cells. Proc. natn. Acad. Sci. U.S.A., 75, 256–60CrossRefGoogle Scholar
  24. Leblen, B., Sen, G. C., Shaila, S., Cabrer, B. and Lengyel, P. (1976). Interferon, double-stranded RNA and protein phosphorylation. Proc. natn. Acad. Sci. U.S.A., 73, 3107–13CrossRefGoogle Scholar
  25. Marcus, P. I. and Sekellick, M. J. (1977). Defective interfering particles with covalently linked ±RNA induce interferon. Nature, Lond., 266, 815–9CrossRefGoogle Scholar
  26. Merigan, T. C., Reed, S. E., Hall, T. S. and Tyrrel, D. A. J. (1973). Inhibition of respiratory virus infection by locally applied interferon. Lancet, i, 563–7CrossRefGoogle Scholar
  27. Metz, D. H. Interferon and interferon inducers. Adv. Drug Res., 10, 101–56Google Scholar
  28. Nolan, D. C., Lauter, C. B. and Lerner, A. M. (1974). Idoxuridine in herpes-simplex virus (type I) encephalitis; experience with 29 cases in Michigan 1966–1971. Ann. intn. Med., 78, 243–6CrossRefGoogle Scholar
  29. Oxford, J. S. (1975). Specific inhibitors of influenza virus replication as potential chemoprophylactic agents. J. antimicrob. Chemother., 1, 7–23CrossRefGoogle Scholar
  30. Oxford, J. S. (1977). Inhibition of the replication of influenza A and B viruses by a nucleoside analogue (ribavirin). J. gen. Virol., 28, 409–11CrossRefGoogle Scholar
  31. Oxford, J. S. and Williams, J. D. (1975). Chemotherapy and control of influenza. J. antimicrob. Chemother., 1, Suppl.Google Scholar
  32. Pitha, P. M. (1977a). Twenty years after. Report of the 5th Katchalsky Conference, Israel. Nature, Lond., 267, 486CrossRefGoogle Scholar
  33. Pitha, P. M. (1977b). Interferon action revisited. Nature, Lond., 269, 374CrossRefGoogle Scholar
  34. Plummer, G. and Ingerson, A. P. (1974). Iododeoxyuridine and herpes viral-encephalitis-lack of inhibitory action against low grade viral replication. Antimicrob. Agents Chemother., 5, 672–3CrossRefGoogle Scholar
  35. Schaeffer, H. J., Beauchamp, L., deMiranda, P., Elion, G., Bauer, D. J. and Collins, P. (1978). 9-(2-Hydroxyethoxymethyl)guanine activity against viruses of the herpes group. Nature, Lond., 272, 583–5CrossRefGoogle Scholar
  36. Schofield, K. P., Potter, C. W., Edey, D., Jennings, R., and Oxford, J. S. (1975). Antiviral activity of ribavirin on influenza infection in ferrets. J. antimicrob. Chemother., 1, (suppl.), 63–9CrossRefGoogle Scholar
  37. Scholtissek, C. (1976). Inhibition of influenza RNA synthesis by virazole (ribavirin). Arch. Virol., 50, 349–52CrossRefGoogle Scholar
  38. Sen, G. C., Leblen, B., Brown, G. E., Kawakita, M., Slattery, E. and Lengyel, P. (1976). Interferon, double-stranded RNA and mRNA degradation. Nature, Lond., 264, 370–2CrossRefGoogle Scholar
  39. Squires, S. (1970). The evaluation of compounds against influenza viruses. Ann. N.Y. Sci., 173, 239–48CrossRefGoogle Scholar
  40. Stellwagen, R. H. and Tomkins, G. M. (1971). Differential effect of 5-bromodeoxyuridine on concentrations of specific enzymes in hepatoma cells in culture (tyrosine aminotransferase/alanine aminotransferase/dehydrogenases/acid phosphatase/inhibition of synthesis). Proc. natn. Acad. Sci. U.S.A., 68, 1147–50CrossRefGoogle Scholar
  41. Stellwagen, R. H. and Tomkins, G. M. (1971). Preferential inhibition by 5-bromodeoxyuridine of the synthesis of tyrosine aminotransferase in hepatoma cell cultures. J. mol. Biol., 56, 167–82CrossRefGoogle Scholar
  42. Streeter, D. G., Witkowski, J. T., Khare, G. P., Sidwell, R. W., Bauer, R. J., Robins, R. K. and Simon, L. N. (1976). Mechanisms of action of 1-β-D-ribofuranosyl-1, 2,4-triazole-3-carboxamide (virazole), a new broad-spectrum antiviral agent. Proc. natn. Acad. Sci. U.S.A., 70, 1174–8CrossRefGoogle Scholar
  43. Tovey, M. G., Begon-Lours, J., Gresser, I. and Morris, A. G. (1977). Marked enhancement of interferon production in 5-bromodeoxyuridine-treated human lymphoblastoid cells. Nature, Lond., 267, 455–7CrossRefGoogle Scholar
  44. Tyrrell, D. A. J. (1976). Interferon and its Clinical Potential. Heinemann Medical, LondonGoogle Scholar
  45. Weil, R. (1961). A quantitative assay for a subviral infective agent related to polyoma virus. Virology, 14, 46–53CrossRefGoogle Scholar
  46. Woodson, B. (1967). Vaccinia mRNA synthesis under conditions which prevent uncoating. Biochem. biophys. Res. Commun., 27, 169–75CrossRefGoogle Scholar
  47. Woodson, B. and Joklik, W. K. (1965). The inhibition of vaccinia virus multiplication by isatin-β-thiosemicarbazone. Proc. natn. Acad. Sci. U.S.A., 54, 946–53CrossRefGoogle Scholar
  48. World Health Organisation (Editorial). (1972). Influenza prophylaxis with amantadine. WHO Bull. 8, 84–7Google Scholar
  49. Zilberstein, A., Federman, P., Schulman, L. and Revel, M. (1976). Phosphorylation in vitro of a protein associated with ribosomes of interferon-treated mouse L-cells. FEBS Lett., 68, 119–24CrossRefGoogle Scholar

Copyright information

© David Edwards 1980

Authors and Affiliations

  • David Edwards

There are no affiliations available

Personalised recommendations